Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anders E Junker

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
BMJ (Clinical Research Ed.)|January 13, 2012
Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trialsTina Vilsbøll, Mikkel Christensen, Anders E Junker, et al.
Journal of Gastroenterology and Hepatology|April 14, 2015
Influence of gastrointestinal factors on glucose metabolism in patients with cirrhosisAnders E Junker, Lise L Gluud, Jens J Holst, et al.
The Journal of Clinical Endocrinology and Metabolism|March 6, 2018
Bone Turnover Markers in Patients With Nonalcoholic Fatty Liver Disease and/or Type 2 Diabetes During Oral Glucose and Isoglycemic Intravenous GlucoseHenrik Maagensen, Anders E Junker, Niklas R Jørgensen, et al.
Ugeskrift for Laeger|January 9, 2019
[Genetic HFE-haemochromatosis]Nils T Milman, Frank V Schiødt, Anders E Junker, et al.
Journal of Hepatology|December 3, 2015
Effects of glucagon-like peptide-1 on glucagon secretion in patients with non-alcoholic fatty liver diseaseAnders E Junker, Lise L Gluud, Gerrit van Hall, et al.
European Journal of Endocrinology|November 30, 2023
Oral glucose has little or no effect on appetite and satiety sensations despite a significant gastrointestinal responseJulius V Lauritsen, Natasha Bergmann, Anders E Junker, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|October 4, 2017
Hyperglucagonemia correlates with plasma levels of non-branched-chain amino acids in patients with liver disease independent of type 2 diabetesNicolai J Wewer Albrechtsen, Anders E Junker, Mette Christensen, et al.
Endocrine Connections|November 30, 2020
No detectable effect of a type 2 diabetes-associated TCF7L2 genotype on the incretin effectDavid S Mathiesen, Jonatan I Bagger, Katrine B Hansen, et al.
Physiological Reports|April 20, 2023
Postprandial dysfunction in fatty liver diseaseJosephine Grandt, Anne-Sofie H Jensen, Mikkel P Werge, et al.
Plos One|June 9, 2025
The hepatic transcriptome is differentially regulated by a standardized meal in healthy individuals compared to patients with fatty liver diseaseJosephine Grandt, Christian D Johansen, Anne-Sofie H Jensen, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
BMJ (Clinical Research Ed.)|January 13, 2012
Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trialsTina Vilsbøll, Mikkel Christensen, Anders E Junker, et al.
Journal of Gastroenterology and Hepatology|April 14, 2015
Influence of gastrointestinal factors on glucose metabolism in patients with cirrhosisAnders E Junker, Lise L Gluud, Jens J Holst, et al.
The Journal of Clinical Endocrinology and Metabolism|March 6, 2018
Bone Turnover Markers in Patients With Nonalcoholic Fatty Liver Disease and/or Type 2 Diabetes During Oral Glucose and Isoglycemic Intravenous GlucoseHenrik Maagensen, Anders E Junker, Niklas R Jørgensen, et al.
Ugeskrift for Laeger|January 9, 2019
[Genetic HFE-haemochromatosis]Nils T Milman, Frank V Schiødt, Anders E Junker, et al.
Journal of Hepatology|December 3, 2015
Effects of glucagon-like peptide-1 on glucagon secretion in patients with non-alcoholic fatty liver diseaseAnders E Junker, Lise L Gluud, Gerrit van Hall, et al.
European Journal of Endocrinology|November 30, 2023
Oral glucose has little or no effect on appetite and satiety sensations despite a significant gastrointestinal responseJulius V Lauritsen, Natasha Bergmann, Anders E Junker, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|October 4, 2017
Hyperglucagonemia correlates with plasma levels of non-branched-chain amino acids in patients with liver disease independent of type 2 diabetesNicolai J Wewer Albrechtsen, Anders E Junker, Mette Christensen, et al.
Endocrine Connections|November 30, 2020
No detectable effect of a type 2 diabetes-associated TCF7L2 genotype on the incretin effectDavid S Mathiesen, Jonatan I Bagger, Katrine B Hansen, et al.
Physiological Reports|April 20, 2023
Postprandial dysfunction in fatty liver diseaseJosephine Grandt, Anne-Sofie H Jensen, Mikkel P Werge, et al.
Plos One|June 9, 2025
The hepatic transcriptome is differentially regulated by a standardized meal in healthy individuals compared to patients with fatty liver diseaseJosephine Grandt, Christian D Johansen, Anne-Sofie H Jensen, et al.
Pageof 2